Protective Efficacy of Cross-Reactive CD8 T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation Threshold
Emergence of a new influenza strain leads to a rapid global spread of the virus due to minimal antibody immunity. Pre-existing CD8+ T-cell immunity directed towards conserved internal viral regions can greatly ameliorate the disease. However, mutational escape within the T cell epitopes is a substantial issue for virus control and vaccine design. Although mutations can result in a loss of T cell recognition, some variants generate cross-reactive T cell responses. In this study, we used reverse genetics to modify the influenza NP336–374 peptide at a partially-solvent exposed residue (N->A, NPN3A mutation) to assess the availability, effectiveness and mechanism underlying influenza-specific cross-reactive T cell responses. The engineered virus induced a diminished CD8+ T cell response and selected a narrowed T cell receptor (TCR) repertoire within two Vβ regions (Vβ8.3 and Vβ9). This can be partially explained by the H-2DbNPN3A structure that showed a loss of several contacts between the NPN3A peptide and H-2Db, including a contact with His155, a position known to play an important role in mediating TCR-pMHC-I interactions. Despite these differences, common cross-reactive TCRs were detected in both the naïve and immune NPN3A-specific TCR repertoires. However, while the NPN3A epitope primes memory T-cells that give an equivalent recall response to the mutant or wild-type (wt) virus, both are markedly lower than wt->wt challenge. Such decreased CD8+ responses elicited after heterologous challenge resulted in delayed viral clearance from the infected lung. Furthermore, mice first exposed to the wt virus give a poor, low avidity response following secondary infection with the mutant. Thus, the protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depend on peptide-MHC-I structural interactions and functional avidity. Our study does not support vaccine strategies that include immunization against commonly selected cross-reactive variants with mutations at partially-solvent exposed residues that have characteristics comparable to NPN3A.
Vyšlo v časopise:
Protective Efficacy of Cross-Reactive CD8 T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation Threshold. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001039
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001039
Souhrn
Emergence of a new influenza strain leads to a rapid global spread of the virus due to minimal antibody immunity. Pre-existing CD8+ T-cell immunity directed towards conserved internal viral regions can greatly ameliorate the disease. However, mutational escape within the T cell epitopes is a substantial issue for virus control and vaccine design. Although mutations can result in a loss of T cell recognition, some variants generate cross-reactive T cell responses. In this study, we used reverse genetics to modify the influenza NP336–374 peptide at a partially-solvent exposed residue (N->A, NPN3A mutation) to assess the availability, effectiveness and mechanism underlying influenza-specific cross-reactive T cell responses. The engineered virus induced a diminished CD8+ T cell response and selected a narrowed T cell receptor (TCR) repertoire within two Vβ regions (Vβ8.3 and Vβ9). This can be partially explained by the H-2DbNPN3A structure that showed a loss of several contacts between the NPN3A peptide and H-2Db, including a contact with His155, a position known to play an important role in mediating TCR-pMHC-I interactions. Despite these differences, common cross-reactive TCRs were detected in both the naïve and immune NPN3A-specific TCR repertoires. However, while the NPN3A epitope primes memory T-cells that give an equivalent recall response to the mutant or wild-type (wt) virus, both are markedly lower than wt->wt challenge. Such decreased CD8+ responses elicited after heterologous challenge resulted in delayed viral clearance from the infected lung. Furthermore, mice first exposed to the wt virus give a poor, low avidity response following secondary infection with the mutant. Thus, the protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depend on peptide-MHC-I structural interactions and functional avidity. Our study does not support vaccine strategies that include immunization against commonly selected cross-reactive variants with mutations at partially-solvent exposed residues that have characteristics comparable to NPN3A.
Zdroje
1. DohertyPC
TurnerSJ
WebbyRG
ThomasPG
2006 Influenza and the challenge for immunology. Nat Immunol 7 449 455
2. ThomasPG
BrownSA
KeatingR
YueW
MorrisMY
2007 Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses. J Immunol 178 3091 3098
3. PircherH
MoskophidisD
RohrerU
BurkiK
HengartnerH
1990 Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346 629 633
4. MooreC
JohnM
JamesI
ChristiansenF
WittC
2002 Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296 1439 1443
5. PriceDA
WestSM
BettsMR
RuffLE
BrenchleyJM
2004 T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21 793 803
6. FernandezC
StratovI
De RoseR
WalshK
DaleC
2005 Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 79 5721 5731
7. Neumann-HaefelinC
McKiernanS
WardS
ViazovS
SpangenbergHC
2006 Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43 563 572
8. ButlerNS
TheodossisA
WebbAI
DunstoneMA
NastovskaR
2008 Structural and Biological Basis of CTL Escape in Coronavirus-Infected Mice. J Immunol 180 3926 3937
9. ButlerNS
TheodossisA
WebbAI
NastovskaR
RamarathinamSH
2008 Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant. PLoS Pathog 4 e1000186
10. TophamDJ
DohertyPC
1998 Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J Virol 72 882 885
11. GogJ
RimmelzwaanG
OsterhausA
GrenfellB
2003 Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci U S A 100 11143 11147
12. RimmelzwaanGF
BoonAC
VoetenJT
BerkhoffEG
FouchierRA
2004 Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res 103 97 100
13. BoonAC
de MutsertG
GrausYM
FouchierRA
SintnicolaasK
2002 Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 76 2567 2572
14. VoetenJT
BestebroerTM
NieuwkoopNJ
FouchierRA
OsterhausAD
2000 Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74 6800 6807
15. TanPT
HeinyAT
MiottoO
SalmonJ
MarquesET
2010 Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. PLoS One 5 e8754
16. RimmelzwaanGF
KreijtzJH
BodewesR
FouchierRA
OsterhausAD
2009 Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 27 6363 6365
17. BerkhoffEG
de WitE
Geelhoed-MierasMM
BoonAC
SymonsJ
2005 Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J Virol 79 11239 11246
18. WahlA
McCoyW
SchaferF
BardetW
BuchliR
2009 T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. J Virol 83 9206 9214
19. WahlA
SchaferF
BardetW
BuchliR
AirGM
2009 HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci U S A 106 540 545
20. KedzierskaK
La GrutaNL
TurnerSJ
DohertyPC
2006 Establishment and recall of CD8+ T cell memory in a model of localized transient infection. Immunol Rev 211 133 145
21. TurnerSJ
KedzierskaK
KomodromouH
La GrutaNL
DunstoneMA
2005 Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8(+) T cell populations. Nat Immunol 6 382 389
22. KedzierskaK
GuillonneauC
GrasS
HattonLA
WebbyR
2008 Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy. Proc Natl Acad Sci U S A 105 19408 19413
23. YoungAC
ZhangW
SacchettiniJC
NathensonSG
1994 The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Cell 76 39 50
24. BelzGT
WodarzD
DiazG
NowakMA
DohertyPC
2002 Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76 12388 12393
25. BelzGT
StevensonPG
DohertyPC
2000 Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol 165 2404 2409
26. HouS
HylandL
RyanKW
PortnerA
DohertyPC
1994 Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 369 652 654
27. SallustoF
LenigD
ForsterR
LippM
LanzavecchiaA
1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 708 712
28. KaechSM
TanJT
WherryEJ
KoniecznyBT
SurhCD
2003 Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4 1191 1198
29. La GrutaNL
TurnerSJ
DohertyPC
2004 Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. J Immunol 172 5553 5560
30. TheodossisA
GuillonneauC
WellandA
ElyLK
ClementsCS
2010 Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci U S A 107 5534 5539
31. TynanFE
BurrowsSR
BuckleAM
ClementsCS
BorgNA
2005 T cell receptor recognition of a ‘super-bulged’ major histocompatibility complex class I-bound peptide. Nat Immunol 6 1114 1122
32. GodfreyDI
RossjohnJ
McCluskeyJ
2008 The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 28 304 314
33. La GrutaNL
RothwellWT
CukalacT
SwanNG
ValkenburgSA
2010 Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J Clin Invest
34. KedzierskaK
TurnerSJ
DohertyPC
2004 Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc Natl Acad Sci U S A 101 4942 4947
35. KedzierskaK
DayEB
PiJ
HeardSB
DohertyPC
2006 Quantification of Repertoire Diversity of Influenza-Specific Epitopes with Predominant Public or Private TCR Usage. J Immunol 177 6705 6712
36. ZhongW
DixitSB
MallisRJ
ArthanariH
LugovskoyAA
2007 CTL recognition of a protective immunodominant influenza A virus nucleoprotein epitope utilizes a highly restricted Vbeta but diverse Valpha repertoire: functional and structural implications. J Mol Biol 372 535 548
37. DeckhutAM
AllanW
McMickleA
EichelbergerM
BlackmanMA
1993 Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. J Immunol 151 2658 2666
38. WherryEJ
TeichgraberV
BeckerTC
MasopustD
KaechSM
2003 Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4 225 234
39. KedzierskaK
VenturiV
FieldK
DavenportMP
TurnerSJ
2006 Early establishment of diverse TCR profiles for influenza-specific CD62Lhi CD8+ memory T cells. Proc Natl Acad Sci U S A 103 9184 9189
40. KedzierskaK
VenturiV
ValkenburgSA
DavenportMP
TurnerSJ
2008 Homogenization of TCR Repertoires within Secondary CD62Lhigh and CD62Llow Virus-Specific CD8+ T Cell Populations. J Immunol 180 7938 7947
41. JabbariA
HartyJT
2006 Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype. J Exp Med 203 919 932
42. MasopustD
HaSJ
VezysV
AhmedR
2006 Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 177 831 839
43. WallaceME
BrydenM
CoseSC
ColesRM
SchumacherTN
2000 Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Immunity 12 547 556
44. KershGJ
MileyMJ
NelsonCA
GrakouiA
HorvathS
2001 Structural and functional consequences of altering a peptide MHC anchor residue. J Immunol 166 3345 3354
45. CluteSC
WatkinLB
CornbergM
NaumovYN
SullivanJL
2005 Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest 115 3602 3612
46. WedemeyerH
MizukoshiE
DavisAR
BenninkJR
RehermannB
2001 Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol 75 11392 11400
47. UrbaniS
AmadeiB
FisicaroP
PilliM
MissaleG
2005 Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med 201 675 680
48. CornbergM
ChenAT
WilkinsonLA
BrehmMA
KimSK
2006 Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J Clin Invest 116 1443 1456
49. AllanW
TabiZ
ClearyA
DohertyPC
1990 Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol 144 3980 3986
50. HoffmannE
MahmoodK
YangC
WebsterR
GreenbergH
2002 Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A 99 11411 11416
51. HolmbergK
MariathasanS
OhtekiT
OhashiPS
GascoigneNR
2003 TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. J Immunol 171 2427 2434
52. SlifkaMK
WhittonJL
2001 Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol 2 711 717
53. MoonJJ
ChuHH
PepperM
McSorleySJ
JamesonSC
2007 Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27 203 213
54. CroweSR
TurnerSJ
MillerSC
RobertsAD
RappoloRA
2003 Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 198 399 410
55. ClementsCS
Kjer-NielsenL
MacDonaldWA
BrooksAG
PurcellAW
2002 The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. Acta Crystallogr D Biol Crystallogr 58 2131 2134
56. MacdonaldW
WilliamsDS
ClementsCS
GormanJJ
Kjer-NielsenL
2002 Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex. FEBS Lett 527 27 32
57. KabschW
1993 Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Cryst 26 795 800
58. McCoyAJ
Grosse-KunstleveRW
AdamsPD
WinnMD
StoroniLC
2007 Phaser Crystallographic Software. J Appl Cryst 40 658 674
59. 1994 The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50 760 763
60. JonesT
ZouJ
CowanS
KjeldgaardM
1991 Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 1991 110 119
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- The Transcription Factor Rbf1 Is the Master Regulator for -Mating Type Controlled Pathogenic Development in
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia